XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:    
Net loss $ (2,055,000) $ (816,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of operating lease right-of-use asset 13,000 20,000
Loss (income) from investments in unconsolidated entities, net 434,000 (25,000)
Stock issued as compensation 0 5,000
Changes in:    
Income taxes payable (168,000) (5,000)
Other current assets 35,000 (43,000)
Accounts payable and accrued expenses 239,000 (27,000)
Operating lease right-of-use liability (13,000) (23,000)
Net cash used in operating activities (1,515,000) (891,000)
Cash flows from investing activities:    
Advances to unconsolidated entities 5,000 604,000
Distributed earnings from unconsolidated entities 279,000 23,000
Distribution from unconsolidated entities outstanding (11,000) 0
Repayments of loans to unconsolidated entities 0 69,000
Capital contributions to unconsolidated entities 0 57,000
Loss from investment in unconsolidated entities   (57,000)
Sale of shares (deposited in 2023 for 2024 transaction) 0 355,000
Net cash used in investing activities 263,000 (180,000)
Cash flows from financing activities:    
Issuance of shares from prior period (355,000) 0
Common stock issued 92,000 0
Additional capital from issuance of common stock 5,083,000 0
Net cash provided by financing activities 4,820,000 0
Net change in cash and cash equivalents 3,568,000 (1,071,000)
Cash and cash equivalents - beginning of period 466,000 1,537,000
Cash and cash equivalents - end of period 4,034,000 466,000
Cash paid for:    
Interest 0 $ 2,000
Supplemental disclosure of noncash investing and financing activities:    
Stock subscriptions receivable 175,000  
Common stock subscribed (175,000)  
Stock to be issued $ 238,000